Dr. Julie Gerberding LEARN MORE Merck & Co. Web site Merck News Room announcing appointment Merck responds to Archives of Internal Medicine article on Vioxx – November 2009 IMAGE SOURCE: Dr. Julie Gerberding / on Web site Adventures in Autism Former Centers for Disease Control and Prevention (CDC) director, Dr. Julie Gerberding, has been named the head of Merck & Co.’s $ 5 billion vaccine
Doctor testifies about Vioxx risk in N.J. trial
Intermittent use of Vioxx or even a day’s use of the painkiller could be enough to cause a heart attack, a prominent heart and medication expert testified on behalf of a man who is suing the maker of the drug, claiming it caused his heart attack.
A 2nd Loss For Merck Over Vioxx
A N.J. jury found that the company had not properly warned patients of the dangers of its drug Vioxx.
$32 million Texas verdict against Merck in Vioxx case reversed
TRENTON, N.J. (AP) - A Texas appeals court overturns a verdict that Merck & Co. lost in the Vioxx case. A Texas jury two years ago awarded the widow of 71-year-old Leonel Garza $32 million. That later was cut to about $7.75 million under Texas damage caps.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved